Anabolic steroids can cause serious health risks, including heart attacks, strokes, reduced fertility, hardening of the arteries, liver damage, the development of male characteristics in women (such ...
Injectable vitamins are being illicitly sold on the e-commerce platform Etsy, with one seller even surprising customers by including loose erectile dysfunction pills in their orders, a new ...
Market Realist on MSN
Popular ointment sold at Walmart and Target recalled over severe health risks for children
The product in question was the Mamisan Pain-Relieving Topical Ointment, and jars of the product were sold in Walmart and ...
The FDA hit Amazon with a warning letter on December 20 for distributing energy supplements for men that contain potentially harmful pharmaceutical ingredients. These products, according to the letter ...
Introduction We showed in a phase II randomised controlled trial (RCT) that oral sildenafil citrate in term labour halved operative birth for fetal distress. We outline the protocol for a phase III ...
Hosted on MSN
Hims vs. Ro: A Comprehensive ED Treatment Comparison
Erectile dysfunction (ED) is more than just a medical condition—it’s a challenge that impacts millions of men’s confidence, relationships, and overall quality of life. Once a topic shrouded in ...
Routine use of drugs like Viagra is associated with an increased risk of developing several types of eye problems that can lead to sudden vision loss and blindness, a new study suggests. Older men who ...
As a men’s health editor, I know firsthand how sensitive erectile dysfunction (ED) can be. I’ve been chasing this dragon for a few years and I’ve done my research so that you don’t have to. Did you ...
Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile dysfunction ...
(RTTNews) - Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its planned actual use trial (AUT). The trial is aimed at ...
Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback